Close
Show

Drug Research

This Drug Research section covers latest in Pharma drug research updates & Pharmaceutical drug research news & Pharma industry research and developments.

Catalent Enters into Strategic Partnership with Editas Medicine to Support Gene Editing Medicine Pipeline


Editas Medicine, Inc., a leading genome editing company, and Catalent, the leading global provider of...
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate

Seven Indian Drugmakers Race To Develop Covid-19 Vaccine


Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E among...
BioInvent's BI-1206 could improve treatment in several cancers

BioInvent’s BI-1206 could improve treatment in several cancers


Alexander Eggermont, MD, PhD, Chief Scientific Officer at the Princess Máxima Center and renowned expert...
Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence in France

Catalent Biologics to Invest $30 Million to Create European Clinical Manufacturing Center of Excellence...


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Artificial DNA

GSK and CureVac announce strategic mRNA technology collaboration


GlaxoSmithKline plc and CureVac announced the signing of a strategic collaboration agreement for the research,...
CMIC Group Establishes a New Biologic Contract Development and Manufacturing Business in Japan

CMIC Group Establishes a New Biologic Contract Development and Manufacturing Business in Japan


CMIC HOLDINGS Co., Ltd. announced the establishment of CMIC BIO Co., Ltd. (hereafter CMIC BIO),...

CEPI expands partnership with Clover to rapidly advance development and manufacture of COVID-19 vaccine...


CEPI, the Coalition for Epidemic Preparedness Innovations, announced the expansion of its partnership with Sichuan...

Samsung Biologics and ImmuneOncia sign multi-product development and manufacturing agreement


Samsung Biologics and ImmuneOncia Therapeutics held a signing ceremony for a contract to develop and...

Biophore India gets DCGI nod to manufacture COVID drug Favipiravir API


Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of...

Vetter Further Expands its Development Service with New Site in Austria


With biopharmaceutical development heavily focused on specialized therapeutics, drug sponsors are increasingly turning to expert...